SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals
Orchid Chemicals and Pharmaceuticals
BSE: 524372|NSE: ORCHIDCHEM|ISIN: INE191A01019|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Aug 04, 15:32
63.90
-0.55 (-0.85%)
VOLUME 345,593
LIVE
NSE
Aug 04, 15:31
64.00
-0.4 (-0.62%)
VOLUME 1,011,497
Announcements on Orchid Chemical

30th-Jul-2015 18:43Source: BSE

Orchid Chemical- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

27th-Jul-2015 17:34Source: NSE

Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Board has approved the Code of practices and procedures for fair disclosure of unpublished price sensitive information (UP...

27th-Jul-2015 17:08Source: BSE

Orchid Chemical- Code of Conduct of Fair Disclosure

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about formulation and adoption of Codes under SEBI (Prohibition of Insider Trading) Regulations, 2015.

22nd-Jul-2015 14:21Source: BSE

Orchid Chemical- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

22nd-Jul-2015 12:08Source: BSE

Orchid Chemical- Shareholding Pattern For June 30, 2015

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.

17th-Jun-2015 16:40Source: BSE

Orchid Chemical- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE

17th-Jun-2015 15:49Source: BSE

Orchid Chemical- Updates

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets (320 mg...

17th-Jun-2015 15:38Source: NSE

Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that Orchid has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Gemifloxacin Mesylate Tablets...

12th-Jun-2015 18:20Source: NSE

Orchid Chemicals & Pharmaceuticals Limited

Orchid Chemicals & Pharmaceuticals Limited has informed the Exchange that the Company has received approval from the USFDA for the Abbreviated New Drug Application (ANDA) for Rivastigmine Capsules in ...

12th-Jun-2015 18:12Source: BSE

Orchid Chemical- Updates

Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Company has received approval from the US FDA for the Abbreviated New Drug Application (ANDA) for Rivastigmine Capsules in 1.5 mg, 3 mg...

1 2 3 4 5 Next >>
Quick Links for Orchid Chemicals and Pharmaceuticals
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.